Bristol-Myers Squibb Co (BMY)
48.99
-0.15
(-0.31%)
USD |
NYSE |
Apr 23, 16:00
49.02
+0.03
(+0.06%)
After-Hours: 20:00
Bristol-Myers Squibb Cash from Operations (Quarterly): 4.252B for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.252B |
| September 30, 2023 | 4.751B |
| June 30, 2023 | 1.887B |
| March 31, 2023 | 2.97B |
| December 31, 2022 | 3.306B |
| September 30, 2022 | 3.687B |
| June 30, 2022 | 2.261B |
| March 31, 2022 | 3.812B |
| December 31, 2021 | 4.057B |
| September 30, 2021 | 5.266B |
| June 30, 2021 | 3.06B |
| March 31, 2021 | 3.824B |
| December 31, 2020 | 3.355B |
| September 30, 2020 | 2.267B |
| June 30, 2020 | 4.493B |
| March 31, 2020 | 3.937B |
| December 31, 2019 | 2.181B |
| September 30, 2019 | 2.556B |
| June 30, 2019 | 2.083B |
| March 31, 2019 | 1.39B |
| December 31, 2018 | 3.555B |
| September 30, 2018 | 1.279B |
| June 30, 2018 | 1.057B |
| March 31, 2018 | 1.175B |
| December 31, 2017 | 1.117B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.713B |
| June 30, 2017 | 1.584B |
| March 31, 2017 | 861.00M |
| December 31, 2016 | 1.443B |
| September 30, 2016 | 1.404B |
| June 30, 2016 | 439.00M |
| March 31, 2016 | -228.00M |
| December 31, 2015 | 884.00M |
| September 30, 2015 | 524.00M |
| June 30, 2015 | 71.00M |
| March 31, 2015 | 626.00M |
| December 31, 2014 | 572.00M |
| September 30, 2014 | 903.00M |
| June 30, 2014 | 1.056B |
| March 31, 2014 | 617.00M |
| December 31, 2013 | 1.41B |
| September 30, 2013 | 1.053B |
| June 30, 2013 | 1.51B |
| March 31, 2013 | -428.00M |
| December 31, 2012 | 836.00M |
| September 30, 2012 | 4.584B |
| June 30, 2012 | 1.134B |
| March 31, 2012 | 387.00M |
| December 31, 2011 | 1.568B |
| September 30, 2011 | 1.698B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
1.887B
Minimum
Jun 2023
5.266B
Maximum
Sep 2021
3.369B
Average
3.355B
Median
Dec 2020
Cash from Operations (Quarterly) Benchmarks
| Amgen Inc | 538.00M |
| Gilead Sciences Inc | 2.169B |
| Johnson & Johnson | 7.863B |
| Karuna Therapeutics Inc (DELISTED) | -111.06M |
| 2seventy bio Inc | -63.60M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.346B |
| Cash from Financing (Quarterly) | 967.00M |
| Free Cash Flow | 12.65B |
| Free Cash Flow Per Share (Quarterly) | 1.929 |
| Free Cash Flow to Equity (Quarterly) | 1.754B |
| Free Cash Flow to Firm (Quarterly) | 4.255B |
| Free Cash Flow Yield | 12.43% |